Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin

Antonio Cascio, Francesca Di Bernardo, Giuseppina Barberi, Antonino Odierna, Maria Lina Mezzatesta, Stefania Stefani, Antonio Cascio, Salvatore Giordano, Chiara Iaria

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We present a case of post-neurosurgical ventriculitis caused by carbapenemase-producing Enterobacter cloacae successfully treated with intraventricular colistin. Enterobacter spp are intrinsically resistant to aminopenicillins, cefazolin, and cefoxitin due to the production of constitutive chromosomal AmpC beta-lactamases. Moreover, extended-spectrum beta-lactamase-producing Enterobacter spp have been identified in the USA and Europe, and carbapenems are considered the drug of choice in these cases. Our isolate was sensitive only to fosfomycin, tigecycline, and colistin, and 6 days of intravenous colistin had failed to eradicate the infection. This case provides clinical evidence to support the administration of intraventricular colistin in such patients
Original languageEnglish
Pages (from-to)66-67
Number of pages2
JournalInternational Journal of Infectious Diseases
Volume20
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin'. Together they form a unique fingerprint.

  • Cite this